Results 41 to 50 of about 15,356,960 (300)

Disability adjusted life years due to acute symptomatic COVID-19 infections in France in 2020 by age and sex.

open access: yes, 2023
Disability adjusted life years due to acute symptomatic COVID-19 infections in France in 2020 by age and sex.
Panayotis Constantinou (3440513)   +12 more
core   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio   +8 more
wiley   +1 more source

Burden of myocardial infarction attributable to road-traffic noise: A pilot study in Belgrade

open access: yesNoise and Health, 2014
The aim of this pilot study was to calculate the disability-adjusted life years (DALY) as a quantification of the burden of myocardial infarction (MI) attributable to road-traffic noise in Belgrade, Serbia. Exposure to road-traffic noise was estimated on
Katarina Paunovic, Goran Belojević
doaj   +1 more source

The global burden of neglected zoonotic diseases: Current state of evidence

open access: yesOne Health, 2023
The majority of emerging infectious diseases are zoonoses, most of which are classified as “neglected”. By affecting both humans and animals, zoonoses pose a dual burden.
Carlotta Di Bari   +12 more
doaj   +1 more source

Studies of technologies addressing diseases among the top ten in disability-adjusted life years globally in 2019.

open access: yes, 2023
Studies of technologies addressing diseases among the top ten in disability-adjusted life years globally in 2019.
Abu Bakarr Rogers (17108692)   +4 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Trends and disparities in tuberculosis burden in Kazakhstan and Mongolia (2017–2021): a comparative analysis using GBD metrics

open access: yesFrontiers in Public Health
BackgroundIn Central Asia, respiratory diseases, particularly tuberculosis (TB), are widespread communicable diseases that significantly impact both individuals and health systems, posing a substantial burden.
Oyunzul Amartsengel   +8 more
doaj   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Median global number of foodborne illnesses, deaths, Years Lived with Disability (YLDs), Years of Life Lost (YLLs) and Disability Adjusted Life Years (DALYs), with 95% uncertainty intervals, 2010.

open access: yes, 2016
Median global number of foodborne illnesses, deaths, Years Lived with Disability (YLDs), Years of Life Lost (YLLs) and Disability Adjusted Life Years (DALYs), with 95% uncertainty intervals, 2010.
Martyn D. Kirk (833166)   +15 more
core   +1 more source

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy